Clinical • P1/2 data • Combination therapy • PD(L)-1 Biomarker • IO biomarker • Metastases
|
BRAF (B-raf proto-oncogene) • CD8 (cluster of differentiation 8) • IL2RA (Interleukin 2 receptor, alpha)
|
BRAF mutation
|
Keytruda (pembrolizumab) • Yervoy (ipilimumab) • Proleukin (aldesleukin) • ANV419